Back to results
US 2014/0274937 A1Published application
Methods of treating hematologic cancers
AssigneeMayo Foundation for Medical Education and Research
InventorsNeil E. Kay, Tait D. Shanafelt
Life of this patent
Estimating the term…
Abstract
This disclosure relates to the treatment of hematologic cancers, for example, cancers of the blood, by methods that include administration of EGCG and at least one of a purine nucleoside analog and an alkylating agent. In particular, methods of treating chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL) are described.
Claims1
A method of treating a hematologic cancer in a subject comprising the steps of:
- (a) administering to the subject an effective amount of EGCG, or a pharmaceutically acceptable salt or derivative thereof;
- and
- (b) administering to the subject an effective amount of one or more of a purine nucleoside analog, or a pharmaceutically acceptable salt or derivative thereof, and an alkylating agent, or a pharmaceutically acceptable salt or derivative thereof
Dependencies are inferred from the claim text.